AKINETON Side Effects

6931273-9 | Blood Creatine Phosphokinase Increased, Myopathy
on Aug 04, 2010 Male patient from DENMARK , 22 years of age, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, myopathy. Akineton dosage: . During the same period patient was treated with FLUANXOL (View Fluanxol Review and Fluanxol Label ). Patient was hospitalized.

6930844-3 | American Trypanosomiasis, Anaemia, Decreased Appetite, Oedema Peripheral, Weight Decreased, Wound
Patient was taking Akineton (View Usage). Patient had the following side effects: american trypanosomiasis, anaemia, decreased appetite, oedema peripheral, weight decreased, wound (What is wound?) on Aug 13, 2010 from BRAZIL Additional patient health information: Female patient , weighting 79.37 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), dementia alzheimer's type and. Akineton dosage: Form Strength: 2mg. During the same period patient was treated with INTRA (Form Strength: 25 Mg) (View Intra Review and Intra Label ), NISTATIN (Form Strength: 50 Mg) (View Nistatin Review and Nistatin Label ). Patient was hospitalized.

6915056-1 | Blood Creatine Phosphokinase Increased, Hyponatraemia, Status Epilepticus
Adverse event was reported on Jul 30, 2010 by a Male patient taking Akineton (View Usage) (Dosage: ) . Location: AUSTRIA , 45 years of age, After Akineton was administered, patient had the following side effects: blood creatine phosphokinase increased, hyponatraemia, status epilepticus. During the same period patient was treated with DEPAKINE CHRONO RETARD (View Depakine Chrono Retard Review and Depakine Chrono Retard Label ), DOMINAL FORTE (View Dominal Forte Review and Dominal Forte Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), XANOR (View Xanor Review and Xanor Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6911757-X | Confusional State, Dyskinesia, Hypertonia
on Jul 29, 2010 Male patient from SPAIN , 83 years of age, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, dyskinesia, hypertonia. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (40 Drops Daily) (View Haloperidol Review and Haloperidol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), UROLOSIN (View Urolosin Review and Urolosin Label ). Patient was hospitalized.


6910789-5 | Coma, Hyponatraemia, Thirst
on Jul 29, 2010 Female patient from SPAIN , 60 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Akineton (View Usage). Patient had the following side effects: coma, hyponatraemia, thirst. Akineton dosage: . During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), IDALPREM (View Idalprem Review and Idalprem Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), UROLOSIN (View Urolosin Review and Urolosin Label ). Patient was hospitalized.

6888442-6 | Blood Creatine Phosphokinase Increased, Myopathy
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: blood creatine phosphokinase increased, myopathy on Oct 27, 2009 from DENMARK Additional patient health information: Male patient , 22 years of age, . Akineton dosage: . During the same period patient was treated with FLUANXOL (View Fluanxol Review and Fluanxol Label ). Patient was hospitalized.

6884883-1 | Anticholinergic Syndrome
Adverse event was reported on Feb 09, 2010 by a Female patient taking Akineton (View Usage) (Dosage: ) was diagnosed with dystonia (What is dystonia?) and. Location: ITALY , child 9 years of age, Patient experienced the following unwanted or unexpected effects: anticholinergic syndrome.

6813733-4 | Abortion Spontaneous
on Jun 21, 2010 Female patient from SWITZERLAND , 28 years of age, was treated with Akineton (View Usage). Patient had the following side effects: abortion spontaneous. Akineton dosage: . During the same period patient was treated with TRANXILIUM (View Tranxilium Review and Tranxilium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DALMADORM (View Dalmadorm Review and Dalmadorm Label ), TOLVON (View Tolvon Review and Tolvon Label ), PROMAZIN (View Promazin Review and Promazin Label ), CLOPIXOL ACUTARD (View Clopixol Acutard Review and Clopixol Acutard Label ).

6795732-4 | Cholestasis
on Jun 15, 2010 Female patient from ITALY , 57 years of age, was diagnosed with mania and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: cholestasis. Akineton dosage: 4 Mg Daily. During the same period patient was treated with CARBOLITHIUM (300 Mg Daily) (View Carbolithium Review and Carbolithium Label ), ALIDOL (60 Drops Daily) (View Alidol Review and Alidol Label ), LORAZEPAM (1 Mg Daily) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6784993-3 | Abortion Induced, Blood Pressure Increased, Fatigue, Hellp Syndrome, Sleep Disorder, Somnolence
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, blood pressure increased, fatigue, hellp syndrome, sleep disorder (What is sleep disorder?), somnolence on Jun 11, 2010 from FRANCE Additional patient health information: Female patient , 40 years of age, was diagnosed with bipolar i disorder and. Akineton dosage: . During the same period patient was treated with SEROPLEX FILM COATED TABLETS (View Seroplex Film-coated Tablets Review and Seroplex Film-coated Tablets Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ).

6758035-X | Hepatitis Acute
Adverse event was reported on Jun 07, 2010 by a Female patient taking Akineton (View Usage) (Dosage: Daily, Prolonged-release, Several Breaks) was diagnosed with psychotic disorder (What is psychotic disorder?), schizophrenia, catatonic type and. Location: GERMANY , 42 years of age, weighting 136.7 lb, Patient had the following side effects: hepatitis acute. During the same period patient was treated with ABILIFY (Single Dose Different, Several Breaks) (View Abilify Review and Abilify Label ), HALDOL (Single Dose Different, Break: 16-) (View Haldol Review and Haldol Label ), CLOZAPINE (Single Dose Diff Several Breaks 25/100mg) (View Clozapine Review and Clozapine Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), CIATYL Z ACUPHASE (View Ciatyl-z Acuphase Review and Ciatyl-z Acuphase Label ), CIATYL Z ACUPHASE (View Ciatyl-z Acuphase Review and Ciatyl-z Acuphase Label ). Patient was hospitalized.

6757002-X | Completed Suicide
on Jan 12, 2010 Female patient from GERMANY , 68 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: completed suicide. Akineton dosage: . During the same period patient was treated with CIPRALEX FILM COATED TABLETS (15-20mg) (View Cipralex Film-coated Tablets Review and Cipralex Film-coated Tablets Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6732871-8 | Hallucination, Visual
on May 12, 2010 Female patient from BRAZIL , weighting 165.3 lb, was diagnosed with dementia alzheimer's type, parkinson's disease (What is parkinson's disease?), hypertension and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual. Akineton dosage: . During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RESPIDON (View Respidon Review and Respidon Label ), DUODOPA (View Duodopa Review and Duodopa Label ).

6717472-X | Neuroleptic Malignant Syndrome
Patient was taking Akineton (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Apr 30, 2010 from JAPAN Additional patient health information: Female patient , 46 years of age, was diagnosed with schizophrenia, hypertension, hypothyroidism, diabetes mellitus and. Akineton dosage: . During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), HALOPERIDOL DECANOATE (View Haloperidol Decanoate Review and Haloperidol Decanoate Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), THYROID TAB (Dried) (View Thyroid Tab Review and Thyroid Tab Label ), INSULIN (View Insulin Review and Insulin Label ).

6691544-0 | Agranulocytosis
Adverse event was reported on Apr 16, 2010 by a Male patient taking Akineton (View Usage) (Dosage: Prolonged-release Tablet) was diagnosed with schizophrenia, paranoid type and. Location: ITALY , 25 years of age, weighting 216.1 lb, After Akineton was administered, patient had the following side effects: agranulocytosis. During the same period patient was treated with LEPONEX (100-850 Mg Daily, 50/100mg Tablet) (View Leponex Review and Leponex Label ), TAVOR (1-6.5mg Per Day Several Breaks) (View Tavor Review and Tavor Label ), HALDOL (5-15 Mg Daily) (View Haldol Review and Haldol Label ), VALPROATE SODIUM (300-1200mg Per Day) (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6686515-4 | Hallucination, Hypertension, Insomnia, Motor Dysfunction, Tremor
on Apr 09, 2010 Female patient from BRAZIL , weighting 88.18 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), blood pressure management and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, hypertension, insomnia, motor dysfunction, tremor. Akineton dosage: . During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), CALTREN (View Caltren Review and Caltren Label ).

6682813-9 | Depressed Level Of Consciousness, Overdose
on Apr 07, 2010 Female patient from JAPAN , 48 years of age, was treated with Akineton (View Usage). Patient had the following side effects: depressed level of consciousness, overdose. Akineton dosage: . During the same period patient was treated with BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DILORAZEPAM (View Dilorazepam Review and Dilorazepam Label ), BROMOVALERYLUREA (View Bromovalerylurea Review and Bromovalerylurea Label ). Patient was hospitalized.

6652384-1 | Hepatitis Acute
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: hepatitis acute on Mar 15, 2010 from GERMANY Additional patient health information: Female patient , 39 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and. Akineton dosage: . During the same period patient was treated with HALDOL JANSSEN (2.5 - 7.5 Mg Daily Per Os) (View Haldol-janssen Review and Haldol-janssen Label ), DIPIPERON (20-40 Mg Per Day) (View Dipiperon Review and Dipiperon Label ), CLOZAPINE (25-275 Mg Daily Per Os) (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

6651357-2 | Atrioventricular Block Complete
Adverse event was reported on Mar 17, 2010 by a Male patient taking Akineton (View Usage) (Dosage: ) . Location: JAPAN , 46 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete. During the same period patient was treated with SERENANCE (Route: Dr) (View Serenance Review and Serenance Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), HYPNOTICS AND SEDATIVES ANTIANXIETICS (View Hypnotics And Sedatives Antianxietics Review and Hypnotics And Sedatives Antianxietics Label ).

6648134-5 | Agranulocytosis
on Mar 15, 2010 Male patient from ITALY , 25 years of age, weighting 216.1 lb, was treated with Akineton (View Usage). Patient had the following side effects: agranulocytosis. Akineton dosage: Prolonged-release Tablet. Patient was hospitalized.

6636446-0 | Depressed Level Of Consciousness, Overdose
on Mar 08, 2010 Female patient from JAPAN , 48 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: depressed level of consciousness, overdose. Akineton dosage: . During the same period patient was treated with BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), DILORAZEPAM (View Dilorazepam Review and Dilorazepam Label ), BROMOVALERYLUREA (View Bromovalerylurea Review and Bromovalerylurea Label ). Patient was hospitalized.

6580539-3 | Atrioventricular Block Complete
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete on Feb 02, 2010 from JAPAN Additional patient health information: Male patient , 46 years of age, . Akineton dosage: . During the same period patient was treated with SERENANCE (Route: Dr) (View Serenance Review and Serenance Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), HYPNOTICS AND SEDATIVES ANTIANXIETICS (View Hypnotics And Sedatives Antianxietics Review and Hypnotics And Sedatives Antianxietics Label ).

6547055-6 | Thrombocytopenia
Adverse event was reported on Jan 08, 2010 by a Female patient taking Akineton (View Usage) (Dosage: ) . Location: FRANCE , 74 years of age, Patient had the following side effects: thrombocytopenia. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), STILNOX (View Stilnox Review and Stilnox Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TIAPRIDE PANPHARMA (View Tiapride Panpharma Review and Tiapride Panpharma Label ).

6521011-6 | Neuroleptic Malignant Syndrome
on Dec 22, 2009 Female patient from JAPAN , 40 years of age, weighting 174.2 lb, was diagnosed with schizophrenia and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: neuroleptic malignant syndrome. Akineton dosage: . During the same period patient was treated with SERENACE (View Serenace Review and Serenace Label ). Patient was hospitalized.

6457925-5 | Neuroleptic Malignant Syndrome
on Nov 19, 2009 Male patient from JAPAN , 40 years of age, was diagnosed with schizophrenia and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. Akineton dosage: . During the same period patient was treated with SERENACE (View Serenace Review and Serenace Label ). Patient was hospitalized.

6384732-4 | Hallucination, Insomnia, Motor Dysfunction, Tremor
Patient was taking Akineton (View Usage). Patient had the following side effects: hallucination, insomnia, motor dysfunction, tremor on Sep 21, 2009 from BRAZIL Additional patient health information: Female patient , 83 years of age, weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), blood pressure management and. Akineton dosage: . During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), CALTREN (View Caltren Review and Caltren Label ).

6382022-7 | Blood Creatine Phosphokinase Increased, Hyperthermia, Rhabdomyolysis
Adverse event was reported on Sep 24, 2009 by a Female patient taking Akineton (View Usage) (Dosage: ) . Location: JAPAN , 18 years of age, After Akineton was administered, patient had the following side effects: blood creatine phosphokinase increased, hyperthermia, rhabdomyolysis. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), SOLANAX (View Solanax Review and Solanax Label ), SG (View Sg Review and Sg Label ).

6342035-8 | Asthenia, Colon Injury, Dyspnoea, Gastrointestinal Disorder, Gastrointestinal Injury, Ill-defined Disorder, Muscle Disorder, Nausea, Pharyngeal Disorder
on Aug 25, 2009 Male patient from UNITED KINGDOM , weighting 185.2 lb, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, colon injury, dyspnoea, gastrointestinal disorder, gastrointestinal injury, ill-defined disorder, muscle disorder (What is muscle disorder?), nausea (What is nausea?), pharyngeal disorder. Akineton dosage: 15mg And 25mg Was Brought To 10mg For Last Time. During the same period patient was treated with ARTANE (15mg And 25mg Was Brought To 10mg For The Last Time) (View Artane Review and Artane Label ), FLUANXOL (15mg And 25mg Was Brought To 10mg For Last Time) (View Fluanxol Review and Fluanxol Label ), RISPERIDON (Times Per 1 Dosage Form) (View Risperidon Review and Risperidon Label ).

6333397-6 | Bradycardia, Hyponatraemia
on Aug 20, 2009 Male patient from GERMANY , 72 years of age, weighting 198.4 lb, was diagnosed with cerebrovascular accident, dementia (What is dementia?), hypertension and was treated with Akineton (View Usage). Patient had the following side effects: bradycardia, hyponatraemia. Akineton dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DIPIPERON (View Dipiperon Review and Dipiperon Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ANTELEPSIN (View Antelepsin Review and Antelepsin Label ), ATACAND (View Atacand Review and Atacand Label ), CONVULEX (View Convulex Review and Convulex Label ), DAPOTUM (View Dapotum Review and Dapotum Label ). Patient was hospitalized.

6304536-8 | Asthenia, Colon Injury, Dyspnoea, Gastrointestinal Disorder, Gastrointestinal Injury, Ill-defined Disorder, Muscle Disorder, Nausea, Pharyngeal Disorder
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: asthenia, colon injury, dyspnoea, gastrointestinal disorder, gastrointestinal injury, ill-defined disorder, muscle disorder (What is muscle disorder?), nausea (What is nausea?), pharyngeal disorder on Aug 06, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 185.2 lb, . Akineton dosage: 15mg And 25mg Was Brought To 10mg For Last Time. During the same period patient was treated with ARTANE (15mg And 25mg Was Brought To 10mg For The Last Time) (View Artane Review and Artane Label ), FLUANXOL (15mg And 25mg Was Brought To 10mg For Last Time) (View Fluanxol Review and Fluanxol Label ), RISPERIDONE (Times Per 1 Dosage Form) (View Risperidone Review and Risperidone Label ).

6293350-8 | Asthenia, Colon Injury, Dyspnoea, Gastrointestinal Disorder, Gastrointestinal Injury, Ill-defined Disorder, Muscle Disorder, Nausea, Pharyngeal Disorder
Adverse event was reported on Jul 22, 2009 by a Male patient taking Akineton (View Usage) (Dosage: 15mg And 25mg Was Brought To 10mg For Last Time) . Location: UNITED KINGDOM , weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: asthenia, colon injury, dyspnoea, gastrointestinal disorder, gastrointestinal injury, ill-defined disorder, muscle disorder (What is muscle disorder?), nausea (What is nausea?), pharyngeal disorder. During the same period patient was treated with ARTANE (15mg And 25mg Was Brought To 10mg For The Last Time) (View Artane Review and Artane Label ), FLUANXOL (15mg And 25mg Was Brought To 10mg For Last Time) (View Fluanxol Review and Fluanxol Label ), RISPERIDONE (Times Per 1 Dosage Form) (View Risperidone Review and Risperidone Label ).

6293257-6 | Asthenia, Colon Injury, Dysmorphism, Dyspnoea, Gait Disturbance, Gastrointestinal Disorder, Gastrointestinal Injury, Muscle Disorder, Nausea
on Jul 22, 2009 Male patient from UNITED KINGDOM , weighting 185.2 lb, was treated with Akineton (View Usage). Patient had the following side effects: asthenia, colon injury, dysmorphism, dyspnoea, gait disturbance, gastrointestinal disorder, gastrointestinal injury, muscle disorder (What is muscle disorder?), nausea (What is nausea?). Akineton dosage: 15mg And 25mg Was Brought To 10mg For Last Time. During the same period patient was treated with ARTANE (15mg And 25mg Was Brought To 10mg For The Last Time) (View Artane Review and Artane Label ), FLUANXOL (15mg And 25mg Was Brought To 10mg For Last Time) (View Fluanxol Review and Fluanxol Label ), RISPERIDONE (Times Per 1 Dosage Form) (View Risperidone Review and Risperidone Label ).

6278199-4 | Hepatitis Acute
on Jul 15, 2009 Male patient from GERMANY , weighting 260.1 lb, was diagnosed with schizophrenia, paranoid type and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: hepatitis acute. Akineton dosage: 1 X 1 Prolonged-released Tablet At 4m. During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), TAVOR (Single Dose Different;break 13-15 Nov 20) (View Tavor Review and Tavor Label ), LEPONEX (25/50/100mg) (View Leponex Review and Leponex Label ). Patient was hospitalized.

6270789-8 | Dyspnoea, Gastrointestinal Disorder, Muscle Disorder
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, gastrointestinal disorder, muscle disorder (What is muscle disorder?) on Jun 23, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 185.2 lb, . Akineton dosage: Times Per 1 Dosage Form. During the same period patient was treated with ARTANE (Times Per 1 Dosage Form) (View Artane Review and Artane Label ), FLUANXOL (Times Per 1 Dosage Form) (View Fluanxol Review and Fluanxol Label ), RISPERIDONE (Times Per 1 Dosage Form) (View Risperidone Review and Risperidone Label ).

6269639-5 | Hallucination, Insomnia, Tremor
Adverse event was reported on Jul 07, 2009 by a Female patient taking Akineton (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?), blood pressure management and. Location: BRAZIL , 83 years of age, weighting 99.21 lb, Patient had the following side effects: hallucination, insomnia, tremor. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), CALTREN (View Caltren Review and Caltren Label ).

6264240-1 | Tachycardia
on Jun 30, 2009 Male patient from ITALY , 32 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: tachycardia. Akineton dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), LEPONEX (12.5-300mg) (View Leponex Review and Leponex Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6228637-8 | Hallucination, Tremor
on Jun 05, 2009 Female patient from BRAZIL , 83 years of age, weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), blood pressure management and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, tremor. Akineton dosage: . During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), CALTREN (View Caltren Review and Caltren Label ).

6221408-8 | Hepatitis Acute
Patient was taking Akineton (View Usage). Patient had the following side effects: hepatitis acute on Jun 03, 2009 from GERMANY Additional patient health information: Male patient , weighting 260.1 lb, was diagnosed with schizophrenia, paranoid type and. Akineton dosage: 1 X 1 Prolonged-released Tablet At 4m. During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), TAVOR (Single Dose Different;break 13-15 Nov 20) (View Tavor Review and Tavor Label ), LEPONEX (25/50/100mg) (View Leponex Review and Leponex Label ). Patient was hospitalized.

6201937-3 | Grand Mal Convulsion
Adverse event was reported on May 18, 2009 by a Female patient taking Akineton (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: SPAIN , 63 years of age, After Akineton was administered, patient had the following side effects: grand mal convulsion. During the same period patient was treated with VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), NOCTAMID (View Noctamid Review and Noctamid Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TRANXILIUM (View Tranxilium Review and Tranxilium Label ). Patient was hospitalized.

6190881-6 | Aphasia, Confusional State, Psychomotor Hyperactivity
on Apr 29, 2009 Female patient from SPAIN , 70 years of age, was diagnosed with cardiovascular disorder, abdominal pain upper and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), confusional state, psychomotor hyperactivity. Akineton dosage: . During the same period patient was treated with POLIBUTIN (View Polibutin Review and Polibutin Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

6124880-7 | Delirium, Feeling Of Despair, Insomnia
on Mar 09, 2009 Male patient from BRAZIL , 56 years of age, weighting 138.9 lb, was diagnosed with tremor, mania and was treated with Akineton (View Usage). Patient had the following side effects: delirium, feeling of despair, insomnia. Akineton dosage: 1tab After Breakfast + Lunch Every 24hr. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6124100-3 | Hypersensitivity
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: hypersensitivity on Mar 09, 2009 from BRAZIL Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with salivary hypersecretion, bipolar disorder (What is bipolar disorder?) and. Akineton dosage: . During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

6108012-7 | Abnormal Behaviour, Aggression, Agitation, Antisocial Behaviour
Adverse event was reported on Mar 02, 2009 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with tremor, schizophrenia and. Location: BRAZIL , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, agitation, antisocial behaviour. During the same period patient was treated with NEOZINE (View Neozine Review and Neozine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6092771-6 | Delirium, Feeling Of Despair, Insomnia
on Feb 16, 2009 Male patient from BRAZIL , 56 years of age, weighting 138.9 lb, was diagnosed with tremor, mania and was treated with Akineton (View Usage). Patient had the following side effects: delirium, feeling of despair, insomnia. Akineton dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6092379-2 | Aggression, Agitation, Antisocial Behaviour
on Feb 16, 2009 Male patient from BRAZIL , weighting 165.3 lb, was diagnosed with tremor, schizophrenia and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: aggression, agitation, antisocial behaviour. Akineton dosage: . During the same period patient was treated with NEOZINE (View Neozine Review and Neozine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6083603-0 | Blood Creatine Phosphokinase Increased, Confusional State, Hypernatraemia, Metabolic Acidosis, Neuroleptic Malignant Syndrome, Pyrexia
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia on Feb 02, 2009 from ITALY Additional patient health information: Female patient , 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder (What is bipolar disorder?) and. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), ANTABUSE (View Antabuse Review and Antabuse Label ), ETUMINA (View Etumina Review and Etumina Label ), ORFIDAL (View Orfidal Review and Orfidal Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

6045897-7 | Gastrointestinal Neoplasm, Tremor
Adverse event was reported on Jan 13, 2009 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension and. Location: BRAZIL , 70 years of age, weighting 132.3 lb, Patient had the following side effects: gastrointestinal neoplasm, tremor. During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5960739-3 | Dependence
on Oct 15, 2008 Male patient from ITALY , 60 years of age, was diagnosed with extrapyramidal disorder and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: dependence. Akineton dosage: . During the same period patient was treated with FLUPHENAZINE (View Fluphenazine Review and Fluphenazine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

5943371-7 | Breast Cancer
on Oct 28, 2008 Female patient from BRAZIL , 86 years of age, was diagnosed with hypothyroidism, musculoskeletal pain and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Akineton dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (Form: 50 Micrograms) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCIUM (View Calcium Review and Calcium Label ).

5934836-2 | Neuroleptic Malignant Syndrome
Patient was taking Akineton (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Oct 24, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, . Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ).